Introduction
Heart enlargement, also known as cardiomegaly, is a condition in which the heart's size increases due to underlying cardiovascular conditions such as hypertension, coronary artery disease, or heart valve problems. Cardiomegaly is not an illness in itself, but rather a sign of certain cardiac disorders that cause the heart muscle to weaken or thicken, reducing its capacity to adequately pump blood.1
Lifestyle interventions play a pivotal role in the management of heart enlargement. Unlike medical treatments such as medications or surgical interventions, lifestyle modifications target the underlying causes of heart diseases by promoting long-term behavioural changes. These interventions focus on dietary improvements, physical activity, weight management, stress reduction, and the elimination of harmful habits like smoking and excessive alcohol consumption. The American Heart Association (AHA) emphasises that lifestyle changes not only prevent the progression of heart disease but can also reverse some of its damaging effects, especially when implemented early.2,3
The link between lifestyle and heart health is well established, with data indicating that approximately 80% of cardiovascular diseases may be prevented through healthy lifestyle choices. These lifestyle changes are especially essential for those who have enlarged hearts because they can reduce strain on the heart, lower blood pressure, and enhance overall cardiovascular function.
Types of cardiomegaly: Symptoms and diagnosis
Cardiomegaly, or heart enlargement, is usually a sign of underlying cardiac problems rather than a distinct condition. The enlargement can be of different types, and identifying them is critical for effective management. The types include the following:1
Dilated cardiomyopathy
This is the most common kind of cardiomegaly and includes the enlargement and thinning of the heart's chambers, notably the left ventricle. Coronary artery disease and infections like myocarditis are frequently associated with this kind. Symptoms include weariness, trouble breathing, and swelling in the legs or abdomen. Echocardiograms and magnetic resonance imaging (MRI) are typical diagnostic procedures used to check the size and function of the heart.
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy causes the heart muscle to thicken, making it harder to pump properly. This disorder is usually hereditary and can occur at any age, but younger people are more likely to be afflicted. Common symptoms include chest discomfort, dizziness, and fainting following strenuous activity. Echocardiograms are frequently used to diagnose hypertrophic cardiomyopathy, and genetic testing may be required if the condition runs in the family.
Restricted cardiomyopathy
It is commonly associated with illnesses such as amyloidosis and sarcoidosis, and it primarily affects the elderly. Common symptoms include shortness of breath and exhaustion, and the condition is identified by utilising imaging techniques such as cardiac MRIs and blood testing to establish underlying reasons.
Arrhythmogenic right ventricular cardiomyopathy (ARVC)
This is a hereditary disorder that causes fat or scar tissue to replace muscle tissue in the heart.
The right ventricle can cause severe arrhythmias. It often affects young adults or athletes, and there are often no symptoms until a catastrophic cardiac event, such as sudden cardiac arrest, happens.
Symptoms and diagnosis
The symptoms of an enlarged heart vary depending on the kind and severity of the illness. However, some frequent ones include:
- Difficulty breathing, particularly while exercising or resting
- Arrhythmias (irregular heartbeats)
- Swelling in the legs or ankles
- Chronic tiredness and weakness
- Chest discomfort
- Episodes of dizziness or fainting
A chest X-ray is often used to diagnose cardiomegaly by looking for apparent heart enlargement. More comprehensive imaging procedures, such as echocardiograms, give a better picture of the heart's anatomy and function. Additional diagnostic tests, such as cardiac MRIs or CT scans, are utilised to analyse the heart tissues and identify underlying reasons. Genetic testing may be conducted if a genetic issue is suspected.
Treatment can prevent or minimise the enlargement of the heart by identifying and resolving the underlying reasons, such as hypertension, valve difficulties, or metabolic abnormalities, if detected early on.4
Importances of lifestyle modifications in addressing cardiomegaly
To manage an enlarged heart, you must make considerable lifestyle changes in addition to medical measures. These modifications are critical, particularly when cardiac enlargement is caused by illnesses such as high blood pressure, obesity, and poor lifestyle choices. Modifications in diet, exercise, smoking, alcohol use, and weight management have been demonstrated to lower cardiac strain, halt disease development, and avoid consequences.
Dietary modifications
Diet is important in controlling cardiomegaly because it has a direct impact on heart function and underlying disorders such as high blood pressure and cholesterol. The DASH diet (Dietary Approaches to Stop Hypertension) is generally suggested since it emphasises the consumption of vegetables, fruits, lean meats, and whole grains while limiting salt. Studies indicate that restricting sodium by decreasing salt consumption can significantly lower blood pressure, lowering the risk of future heart enlargement.6
Furthermore, omega-3 fatty acids, which are present in fish such as mackerel and salmon, have been shown to decrease inflammation and prevent abnormal cardiac rhythms, both of which are
important in maintaining heart health. High-fibre diets, such as whole grains and legumes, also help to reduce cholesterol levels, reducing the burden on the heart.7
Physical activity
Exercise is essential in controlling an enlarged heart. Regular aerobic exercise improves heart function, decreases blood pressure, and aids in weight control, all of which are helpful to the heart. Walking, swimming, and biking are all good ways to keep your heart healthy without overworking it. Patients are often recommended to engage in these activities under medical guidance. Overexertion may aggravate cardiomegaly, and thus, medical care is recommended.5
Structured exercise regimens have been shown in studies to ease symptoms in heart failure patients, reduce hospital admissions, and improve overall quality of life. Low-impact hobbies, such as yoga, can also benefit cardiovascular health by lowering stress and encouraging relaxation.8,9
Weight loss
Weight management is vital for lowering cardiac strain. Obesity increases the burden on the heart, which can lead to enlargement. Individuals can reduce the stress on their heart by decreasing weight, particularly visceral fat around key organs. Even modest weight loss has been associated with enhanced cardiac function and decreased heart size.10
Quit smoking
Chemicals in tobacco harm blood vessels. These make the heart work harder, aggravating the enlargement. Quitting smoking is one of the most effective methods to slow the progression of cardiomegaly and lower the risk of complications such as heart attacks and strokes. Behavioural therapy, nicotine replacement therapies, and pharmaceuticals such as varenicline have been effective in smoking cessation efforts.11
Limiting alcohol
Excessive alcohol intake is a common cause of cardiomegaly, particularly alcoholic cardiomyopathy, a disorder in which chronic alcohol misuse damages the heart muscle. Individuals can prevent additional harm and perhaps cure certain symptoms of alcohol-induced heart enlargement if they reduce their alcohol intake to moderate levels (one drink per day for women and two drinks per day for men) or avoid it totally.12
Long-term advantages of lifestyle interventions in managing cardiomegaly
Adopting and maintaining lifestyle adjustments has significant long-term advantages for people with cardiomegaly. These changes, particularly in nutrition, exercise, and overall health behaviours, are critical for minimising the stress on the heart, improving its function, and preventing future enlargement. The emphasis on sustainable lifestyle choices not only aids in symptom management but also plays an important role in avoiding problems and enhancing overall cardiovascular health.1
Slowing disease progression
A significant advantage of lifestyle therapies is their ability to prevent or reduce heart enlargement. Factors, including excessive blood pressure, obesity, and coronary artery disease, frequently induce cardiomegaly. Making long-term changes, such as adopting a low-sodium diet (like the DASH diet), has been shown to lower blood pressure, reduce the strain on the heart, and prevent future hypertrophy.6
Regular aerobic activity improves the heart's capacity to pump blood effectively while also lowering blood pressure and cholesterol levels, both of which are vital for controlling cardiomegaly. Over time, these lifestyle changes might lessen the need for invasive procedures such as surgery, emphasising their preventative value.9,10
Improved heart structure and function
Losing extra body weight, especially visceral fat, has a significant impact on heart function. Weight reduction lessens strain on the heart, perhaps improving its structure. A procedure called reverse cardiac remodelling can occur, in which the heart's size and function gradually return to normal when the load is reduced. According to research, people who lose weight through lifestyle changes frequently see considerable improvements in heart size and cardiomegaly symptoms.
Similarly, quitting smoking and limiting alcohol use offer significant benefits for heart health. Quitting smoking considerably reduces the chance of heart failure, although restricting alcohol intake can restore some of the heart muscle damage caused by persistent alcohol use (alcoholic cardiomyopathy), especially when detected early.11,12
Increased quality of life and longevity
Individuals who practice heart-healthy lifestyle modifications often have a higher quality of life. Regular physical exercise not only strengthens the heart, but it also boosts mood, energy, and mental health. Long-term lifestyle improvements, particularly those involving blood pressure control, cholesterol reduction, and weight management, are substantially associated with increased life expectancy. Cardiomegaly can help people live longer, healthier lives by lowering their risk of heart attacks, strokes, and abrupt cardiac events.9,10
Economic benefits and lower healthcare costs
Lifestyle modifications are also inexpensive, lowering the need for expensive medical treatments. Patients may be able to avoid costly procedures, hospitalisations, and drugs if cardiomegaly does not develop. For example, those who successfully control their hypertension with diet and exercise are less likely to become dependent on antihypertensive medicines in the long run. This can result in significant cost savings for people and healthcare systems.
Summary
Long-term management of cardiomegaly (enlarged heart) requires lifestyle modifications. Key measures, such as a healthier diet, regular physical exercise, weight control, and avoiding smoking and excessive alcohol use, provide considerable health benefits. These adjustments can reduce or even stop disease progression by addressing underlying factors such as excessive blood pressure and obesity.
Exercise and weight loss help to improve heart function, perhaps correcting some structural heart problems. Patients' energy levels increase with time, as does their weariness and mental wellness. Adopting these practices also reduces the chance of complications, such as heart failure and stroke, which increases life expectancy. These actions are also cost-effective, as they reduce the need for expensive therapies and hospital stays.
Furthermore, mental health advantages such as reduced anxiety and stress improve patients' adherence to these lifestyle adjustments, resulting in better overall results for individuals with cardiomegaly. Integrating these innovations into patient care guarantees better and longer lives.
References
- Ciarambino T, Menna G, Sansone G, Giordano M. Cardiomyopathies: An Overview. Int J Mol Sci [Internet]. 2021 [cited 2025 Oct 23]; 22(14):7722. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303989/.
- Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. Int J Cardiol [Internet]. 2013 [cited 2025 Oct 23]; 168(2):934–45. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819990/.
- Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation [Internet]. 2019 [cited 2025 Oct 23]; 140(11). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000677.
- Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet [Internet]. 2020 [cited 2025 Oct 23]; 396(10258):1223–49. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673620307522.
- Lavie CJ, Arena R, Swift DL, Johannsen NM, Sui X, Lee D, et al. Exercise and the Cardiovascular System: Clinical Science and Cardiovascular Outcomes. Circ Res [Internet]. 2015 [cited 2025 Oct 23]; 117(2):207–19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493772/.
- Challa HJ, Ameer MA, Uppaluri KR. DASH Diet To Stop Hypertension. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Oct 23]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482514/.
- Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases. Journal of the American College of Cardiology [Internet]. 2009 [cited 2025 Oct 23]; 54(7):585–94. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0735109709017094.
- Piepoli MF. Exercise training in heart failure. Curr Heart Fail Rep [Internet]. 2006 [cited 2025 Oct 23]; 3(1):33–40. Available from: http://link.springer.com/10.1007/s11897-006-0029-3.
- Mounsey LA, Guo M, Lau ES, Ho JE. Exercise Training in Heart Failure: Clinical Benefits and Mechanisms. Circulation Research [Internet]. 2025 [cited 2025 Oct 23]; 137(2):273–89. Available from: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.124.325533.
- Lavie CJ, Alpert MA, Arena R, Mehra MR, Milani RV, Ventura HO. Impact of Obesity and the Obesity Paradox on Prevalence and Prognosis in Heart Failure. JACC: Heart Failure [Internet]. 2013 [cited 2025 Oct 23]; 1(2):93–102. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213177913000607.
- Messner B, Bernhard D. Smoking and Cardiovascular Disease: Mechanisms of Endothelial Dysfunction and Early Atherogenesis. ATVB [Internet]. 2014 [cited 2025 Oct 23]; 34(3):509–15. Available from: https://www.ahajournals.org/doi/10.1161/ATVBAHA.113.300156.
- Piano MR, Phillips SA. Alcoholic cardiomyopathy: Pathophysiologic insights. Cardiovasc Toxicol [Internet]. 2014 [cited 2025 Oct 23]; 14(4):291–308. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177522/.

